Perioperative low molecular weight heparin for infrageniculate bypass

Journal of Vascular Surgery

Volumn 25, Issue 5, 1997, Pages 796-802

  McMillan, W D ^a   McCarthy, W J ^a   Lin, S J ^a   Matsumura, J S ^a   Pearce, W H ^a   Yao, J S T ^a   Bower, T C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; POLITEF; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ATHEROSCLEROSIS; BYPASS SURGERY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GANGRENE; GRAFT PATENCY; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POLITEF IMPLANT; POSTOPERATIVE CARE; PRIORITY JOURNAL; THROMBECTOMY; THROMBOSIS;

EID: 0030915148     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(97)70208-8     Document Type: Article

References (27)

1. M Levine M Gent J Hirsh J Leclerc D Anderson J Weitz A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis N Engl J Med 334 1996 677 681
2. MMW Koopman P Prandoni F Piovella PA Ockelford DP Brandjes J van der Meer Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home N Engl J Med 334 1996 682 687
3. A Calabrò F Piarulli D Milan A Rossi G Coscetti G Crepaldi Clinical assessment of low molecular weight heparin effects in peripheral vascular disease Angiology 44 1993 188 195
4. RA Edmondson AT Cohen SK Das MB Wagner VV Kakkar Low–molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting Lancet 344 1994 914 918
5. E Holmer C Mattsson S Nilsson Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits Thromb Res 25 1982 475 485
6. E Young MH Prins MN Levine J Hirsh Heparin binding to plasma proteins, an important mechanism for heparin resistance Thromb Haemost 67 1992 639 643
7. B Boneu C Caranobe Y Cadroy F Dol AM Gabaig D Dupouy Pharmacokinetic studies of standard unfractionated heparin and low molecular weight heparins in the rabbit Semin Thromb Hemost 14 1988 18 27
8. L Bara E Billaud G Gramond A Kher M Samama Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration Thromb Res 39 1985 631 636
9. AD Whittemore AW Clowes NP Couch JA Mannick Secondary femoropopliteal reconstruction Ann Surg 193 1981 35 42
10. RB Rutherford DN Jones S-E Bergentz D Bergqvist AM Karmody H Dardik The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass J Vasc Surg 1 1984 765 773
11. FJ Veith SK Gupta E Ascer S White-Flores RH Samson LA Scher Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions J Vasc Surg 3 1986 104 114
12. WJ McCarthy WH Pearce WR Flinn GS McGee R Wang JST Yao Long-term evaluation of composite sequential bypass for limb-threatening ischemia J Vasc Surg 15 1992 761 770
13. LL Stept WR Flinn WJ McCarthy III ST Bartlett JJ Bergan JS Yao Technical defects as a cause of early graft failure after femorodistal bypass Arch Surg 122 1987 599 604
14. RD Hull GE Raskob D Rosenbloom J Lemaire GF Pineo B Baylis Optimal therapeutic level of heparin therapy in patients with venous thrombosis Arch Intern Med 152 1992 1589 1595
15. CA Clyne TJ Archer LK Atuhaire AD Chant JH Webster Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts Br J Surg 74 1987 246 248
16. RM Green LR Roedersheimer JA DeWeese Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency Surgery 92 1982 1016 1026
17. TR Kohler JL Kaufman G Kacoyanis A Clowes MC Donaldson A Kelly Effect of aspirin and dipyridamole on patency of lower extremity bypass grafts Surgery 96 1984 462 466
18. C McCollum C Alexander G Kenchington PJ Franks R Greenhalgh Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial J Vasc Surg 13 1991 150 162
19. B Satiani A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts Angiology 36 1985 608 616
20. H Schweiger P Klein S Ruf R Meister Avoiding early failure of tibial prosthetic bypass grafts Thorac Cardiovasc Surg 2 1987 148 150
21. DB Walsh RM Zwolak MD McDaniel JR Schneider JL Cronenwett Intragraft drug infusion as an adjunct to balloon catheter thrombectomy for salvage of thrombosed infragenicular vein grafts: a preliminary report J Vasc Surg 11 1990 753 760
22. G Kretschmer F Herbst M Prager T Sautner E Wenzl GA Berlakovich A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis Arch Surg 127 1992 1112 1115
23. G Kretschmer E Wenzl F Piza P Polteraver H Ehringer E Minar The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970-85) and interim evaluation of a controlled clinical trial Surgery 102 1987 453 459
24. G Kretschmer E Wenzl O Wagner P Polteraver H Ehringer E Minar Influence of anticoagulant treatment preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease Br J Surg 73 1986 689 692
25. D Rosenthal MJ Mittenthal DM Ruben DH Jones JW Estes PE Stanton Jr The effects of aspirin, dipyridamole and warfarin in femorodistal reconstruction: long-term results Am Surg 53 1987 477 481
26. B Arfvidsson F Lundgren C Drott T Scherstén K Lundholm Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery Am J Surg 159 1990 556 560
27. AV Sterpetti RD Schultz RJ Feldhaus DJ Peetz Jr Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft: is it worthwhile to preserve the autologous saphenous vein? J Vasc Surg 2 1985 907 912